Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Family Medicine | Internal Medicine | Nursing | Oncology | Psychiatry | Journal

Back to Journal Articles

Predictors of QoL ID’d for Long-Term Lymphoma Survivors

Last Updated: December 04, 2012.

 

Older age, comorbidity, negative perception of cancer's impact predict poor quality of life

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
A considerable proportion of long-term survivors of non-Hodgkin's lymphoma have persistently low or worsening quality of life, which is predicted by age, comorbidity, and the perception of cancer's impact, according to research published online Dec. 3 in the Journal of Clinical Oncology.

TUESDAY, Dec. 4 (HealthDay News) -- A considerable proportion of long-term survivors of non-Hodgkin's lymphoma (NHL) have persistently low or worsening quality of life (QoL), which is predicted by age, comorbidity, and the perception of cancer's impact, according to research published online Dec. 3 in the Journal of Clinical Oncology.

Sophia K. Smith, Ph.D., of the Duke Cancer Institute in Durham, N.C., and colleagues surveyed 566 NHL survivors (52 percent women; 87 percent white) at a mean of 15.3 years post-diagnosis, who had participated in a study at 10.4 years post-diagnosis. Changes in QoL were examined, and clinical, demographic, or psychosocial predictors for poor outcomes were assessed.

The researchers found that 32 percent of participants reported persistently high or improved QoL, but 42 percent reported persistently low or worsening QoL. Improvements in physical health were reported by participants who received only biologic systemic therapy. Independent predictors of poor QoL included older age, more comorbidity, and an increasing negative and decreasing positive perception of the impact of cancer. Correlates of a negative perception of cancer's impact included lymphoma symptom burden, less social support, and having received a transplant.

"Moderate to severe symptom burden, limited social support, or having received a [transplant] should alert the clinician to potential need for supportive services," the authors write. "Perceptions of cancer's impact are associated with QoL cross-sectionally and longitudinally; modifying these perceptions may thus provide a strategy for improving QoL."

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2012 HealthDay. All rights reserved.


Previous: Psychotropics Seem to Be Appropriately Prescribed to Teens Next: Resistance Exercise Offers More Prolonged Glycemic Control

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.